Recent Story Posts
Community
Adonis Timone Aims to Create Change with Advocates for Youth
Culture
Reducing our Footprint: It’s Time to Get More Ambitious
Innovation
Four Questions with Behzad Kharabi and Bijal Shah: The Need for New Therapies in Adult Acute Lymphoblastic Leukemia
Recent Press Releases
-
June 12, 2021
Longer-term Data for Kite’s Yescarta® in Relapsed or Refractory Follicular Lymphoma Demonstrate Substantial Survival Improvement Over Current Therapies in Comparative Analysis -
June 10, 2021
U.S. Food and Drug Administration Approves New Formulation of Epclusa®, Expanding Pediatric Indication to Treat Children Ages 3 and Older With Chronic Hepatitis C
For more information, contact us.
Phone:
1-800-GILEAD-5 (1-800-445-3235)
1-800-GILEAD-5 (1-800-445-3235)